Pharmalot… Pharmalittle… The Weekend Nears
1 CommentBy Ed Silverman // July 16th, 2010 // 6:59 am
And so another working week will soon draw to a close. And what a week it was. How about those Avandia developments? Well, time to think of other endeavors. Perhaps a dip in the pool or a day at the beach? A night at the movies (a day at the races?) As for us, we plan to spend time with one or two short people and catch up on some rest. Whatever you do, we hope you enjoy yourself. Meanwhile, join us for a cup of stimulation and survive the day. See you soon…
Toxicology Sinks Vernalis, Biogen’s Parkinson’s Drug (Reuters)
UK’s NICE OKs Sanofi’s Multaq Heart Drug (Bloomberg News)
Novartis Strikes Tentative Deal To Settle Zelnorm Lawsuits (Dow Jones)
FDA Reviewers Question Avastin Breast Cancer Data (Reuters)
Merck Ends Development Of HIV Drug (AIDSMeds)
Adolor Cuts 30 Percent Of Staff (Philadelphia Business Journal)
Elan Settles Zonegran Investigation For $204M (Bloomberg News)
Tekmira Gets $140M Defense Contract For Ebola Virus (Xconomy)
Certain Genes Linked To Kidney Disease In Blacks (Reuters)
Mylan Pays $550M For Bioniche’s Injectables Biz (InPharmaTechnologist)
FDA Reviews ARBs For Cancer Risk (MedPage Today)
photo thx to tipiro on Flickr creative commons
John English
Ed:
Your note about (A day at the races?) is prescient - how did you know we are scheduled to be part of a ’surprise birthday party’ at Monmouth Park this weekend?
Just looking forward to a day of “horsing around’ - and praying for good weather.
(And classify this as “there’s a first time for everything.” Before this, the only tracks I have been on were the ones I was running the mile on.)